Tag: CLNO

Blue Horseshoe Stocks: FSLR, VHGI, JRRD

First Solar, Inc. FSLR

On February 27th, FSLR appeared on our watchlist as a stock we were monitoring  for a bounce opportunity off of an earnings gap-down. Following that report, it was as low as 24.46. This week, we saw a big pop out of FSLR, running as high as 41.00, for a whopping 68% gain. Quite impressive, as it is not often that we see such sizable gains off of a stock traded on the NASDAQ.

Following that run, a consolidation ensued, as it found a base at 35.95; a level that we’d like to see held as future support.

___

VHGI Holdings, Inc. VHGI

We’ve been following VHGI for a LONG time. More specifically, since December 9th, 2011. In that period of roughly 16 months, we’ve had quite a bit of success trading this stock.

We saw an intitial run from .21-.52, 148% for our first ever alert on VHGI. We then proceeded to see another move from .225 in December, to .746 (+230%) in January of last year. But it didn’t stop there.

After taking a bit of a hiatus, VHGI cropped up on our radars once again, on June 25th. By that time, it had come all the way down to .055. A few weeks hence, we celebrated a gain of 255% as the stock touched .195.

We then backed off for awhile, until it began appearing once again in our extended watchlist last month March 1st. This is after we noticed it coming off of its 52-week lows, and out of the sub-penny range. That was on a Friday, and the PPS had reach one penny exactly. By the following Monday, trades were going off at .048, marking another solid move, this time, to the tune of 380%

Once again, the play appeared on our watchlists, on April 2nd, and as a feature in our reports on April 3rd. At that time, we observed a run from .0195, to a break of its previous swing high of .048 (which nearly coincides with the 200DMA at .045) up to a high of .07, adding close to 260% in added profit. The significance of breaking the 200DMA is huge for the bullishness of VHGI. We’d like to see support hold there (~.05) moving forward.

If anyone knows this stock, it would be us. It stands as one of the longest-running tracked stocks in our history.

___

Journal of Radiology, Inc. JRRD

JRRD has appeared in our extended watchlist, for the first time on April 2nd and 3rd. Following that time, the stock was trading as low as .0005, most recently on Wednesday. Yesterday, we observed a high of .0025, marking a huge 400% rip in just a few day’s time. Those of you who didn’t have it on your watchlists from the time of our original alerts, could still have managed gains of up to 67%, as it ran from .0015 to .0025 during yesterday’s session alone.

___

Extended Watchlist:
SFRX, SKTO, PSPW, CLNO, CLNT, FST

STKO, PNCH & Extended Watchlist

SK3 Group, Inc. SKTO

SKTO dropped news regarding the acquisition of a cannabis-related company, sending the stock on a ride yesterday of over 480%

According to the release, SKTO added a significant amount to its bottom line, as the acquisition target is a company with  more than 12M dollars in licensing agreements.

With this new development, SKTO has effectively placed itself in the list of marijuana stocks that we’ve been monitoring for several months. We have been essentially scanning the entire sector continuously during that time, which has yielded us some sizable profits so far.

In case you might have missed a few here and there, this is a rundown of every single cannabis stock we’ve looked at recently:  PHOT, MJNA, CBIS, RFMK, ERBB, GRNH, MDBX, MWIP, TRTC, EXMT, EDXC. In addition to STKO, here are some other new stocks in the field that have caught our attention: FSPM, NRBT, GTLA, GWPRF, HESG, PARS, SRER, SFIO, NVLX.

MIAMI, FL, Mar 11, 2013 (MARKETWIRE via COMTEX) — SK3 Group, Inc. (OTC Pink: SKTO) today announces that it has acquired Medical Greens (TM) and has changed its business model to focus purely in the medical marijuana space. Medical Greens (TM) currently provides licensing, management, and logistic services for Medical Marijuana collectives throughout California. In 2013 alone, Medical Greens (TM) has already contracted over $12.5 Million in licensing and service agreements.

___

IC Punch Media, Inc. PNCH

PNCH (formerly ICPA) has been a focus of ours a few times on the years past, and has brought us huge percentage gains. The first run we ever observed from this play took it from triple-zero country all the way up over a nickel, so we are well aware of its track record for explosive gains.

Yesterday PNCH once again triggered our scanners as it broke a key resistance point at .005, an area on the chart that it has been struggling to surpass since November.  Up until that time, .005 had acted as support, and we’ve been waiting for a move back above it, and now that it has, we’d like to see that once again become the support level for the stock.

___

Extended Watchlist:
FRTD, MDIN, CLNO, PPHM, GNIN, CLSN, ECTE, GLUU

YIPI, ARNA & Today’s Extended Watchlist

YIPI recently caught our attention, as a stock that has been on a steady incline for months now. Yesterday’s activity was exciting, and despite the Dow being down over 100 points, YIPI managed a nearly 60% gain.

Any stock that is doing this well during a relatively turbulent time is certainly worth a second look.

The company also had some news out yesterday:

Yippy, Inc. (YIPI) and MuseGlobal to Merge, Offering Unified Access to a Data Cloud of Curated Content

http://www.yippy.com

____

Arena Pharmaceuticals, Inc. ARNA

This stock has appeared on our newsletters before. On May 11th, we stated that “we want to watch this play carefully heading into the month of June, being the target month for FDA approval, as we believe that there could be trading opportunities in the meantime”

We turned out to be correct. In the days following our alert, the stock was trading as low as 5.50, and yesterday reached a high of 7.23, for a 31% gain. Should the company indeed receive the FDA approval it seeks, that 31% could be just a drop in bucket of some much larger gains.

We will keep our eyes peeled for any additional press coming over the wires. In the meantime here’s a link to this morning’s announcement:

Arena and VIVUS Race to Be the First in the Lucrative Anti-Obesity Drug Market

____
Extended Watchlist:

EEGC, CLNO